Skip to main content
. 2019 Sep 17;68(12):1025–1034. doi: 10.1007/s00011-019-01284-2

Fig. 5.

Fig. 5

SSc was effective against drug-resistant HBV. HepG2 cells were transfected with wild-type HBV or HBV mutants resistant to lamivudine (LAM), telbivudine (TbL), or entecavir (ETV). The cells were then treated with 1% DMSO or SSc (10–20 μg/mL) followed by measurement of the cellular HBV DNA by real-time PCR